CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-15 | O'Byrne Jason EVP & Chief Financial Officer | Grant or award · Stock Option (Right to Buy) 10b5-1 | +150,000 | 150,000 | ||
| 2024-11-06 | de Verneuil Vanina EVP and General Counsel | Sale 10b5-1 | −4,397 | $10.11 | $44K | 56,973 |
| 2024-11-05 | de Verneuil Vanina EVP and General Counsel | Sale 10b5-1 | −2,347 | $9.47 | $22K | 61,370 |
| 2024-11-01 | de Verneuil Vanina EVP and General Counsel | Sale 10b5-1 | −1,403 | $7.20 | $10K | 63,717 |
| 2024-10-23 | SCANGOS GEORGE A Director | Other acquisition | +598,270 | 719,259 | ||
| 2024-10-23 | SCANGOS GEORGE A Director | Other disposition | −598,270 | 1,151,730 | ||
| 2024-10-23 | SCANGOS GEORGE A Director | Other acquisition | +598,270 | 598,270 | ||
| 2024-10-23 | SCANGOS GEORGE A Director | Other disposition | −598,270 | 1,151,730 | ||
| 2024-09-09 | Napolitano Janet Director | Sale 10b5-1 | −12,190 | $7.80 | $95K | 11,616 |
| 2024-07-15 | Eisner Mark EVP and Chief Medical Officer | Grant or award | +75,000 | 75,000 | ||
| 2024-07-15 | Eisner Mark EVP and Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2024-06-12 | De Backer Marianne Chief Executive Officer | Other disposition | −53,118 | 625,339 | ||
| 2024-06-12 | De Backer Marianne Chief Executive Officer | Other acquisition | +53,118 | 53,118 | ||
| 2024-06-11 | Ramasastry Saira Director | Sale | −4,000 | $10.95 | $44K | 14,619 |
| 2024-05-30 | Sigal Charles Elliott Director | Grant or award | +8,000 | 23,806 | ||
| 2024-05-30 | Sigal Charles Elliott Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2024-05-30 | SCANGOS GEORGE A Director | Grant or award | +8,000 | 120,989 | ||
| 2024-05-30 | SCANGOS GEORGE A Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2024-05-30 | SATO VICKI L Director | Grant or award | +8,000 | 1,323,351 | ||
| 2024-05-30 | SATO VICKI L Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 |
Page 8 of 54 · 1,063 trades